Polymyalgia rheumatica - A clinical overview;Polymyalgia rheumatica - Ein klinischer überblick

Journal fur Mineralstoffwechsel

Volumn 11, Issue 1, 2004, Pages 37-39

  Nothnagl, Thomas ^a   Leeb, Burkhard F ^b  

^a II Medizinische Abteilung   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AGE DISTRIBUTION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ELDERLY CARE; FEMALE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RHEUMATIC POLYMYALGIA; SHORT SURVEY; STANDARD;

EID: 1842531169     PISSN: 10237763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Epperly TD, Moore KE, Harrover JD. Polymyalgia rheumatica and temporal arteritis. Fam Physician 2000; 15; 62: 789-96.
2. Cimmino MA, Zaccaria A. Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 2000; 18 (Suppl 20): S9-11.
3. Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434-9.
4. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981; 40: 1-5.
5. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-80.
6. Wilke WS, Wysenbeek AJ, Krall PL, Segal AM. Masked presentation of giant-cell arteritis. Cleve Clin Q 1985; 52: 155-9.
7. Nobunaga M, Yoshioka K, Yasuda M, Shingu M. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med 1989; 28: 452-6.
8. Bird HA. Treatment of Polymyalgia - a role for Biologics. Ann Rheum Dis 2003; 62 (Suppl 1): Abstract 84.
9. Gonzalez-Gay MA, Rodriguez-Valverde V, Blanco R, Fernandez-Sueiro JL, Armona J, Figueroa M, Martinez-Taboada VM. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. Arch Intern Med 1997; 157: 317-20.
10. Weyand C, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ. Cortico-steroid requirements in polymyalgia rheumatica. Arch Int Med 1999; 159: 577-84.
11. Evans JM, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am 2000; 26: 493-515.
12. Feinberg HL, Sherman JD, Schrepferman CG, Dietzen CJ, Feinberg GD. The use of methotrexate in polymyalgia rheumatica. J Rheumatol 1996; 23: 1550-2.
13. Ferraccioli G, Salaffi F, DeVita S, Casatta L, Bartoli E. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 1996; 23: 624-8.
14. De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/ polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 1986; 45: 136-8.
15. Leeb BF, Bird HA, Nesher G, Andel I, Hueber W, Logar D, Montecucco CM, Rovensky J, Sautner I, Sonnenblick M. EULAR response criteria for Polymyalgia Rheumatica. Results of an initiative of the European collaborating Polymyalgia Rheumatica group (subcommittee of ESCISIT). Ann Rheum Dis 2003; 62: 1189-94.
16. Leeb BF, Bird HA. A disease activity score for Polymyalgia Rheumatica - PMR-AS. Ann Rheum Dis 2003; in press.